Combining MYC inhibitors with metabolic drugs may boost cancer treatment efficacy

Northwestern Medicine investigators have discovered a new combination approach that may improve the efficacy of MYC inhibitor drugs for treating aggressive and treatment-resistant cancers, according to a recent Northwestern Medicine study published in Science Advances.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup